![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DNPH1 |
Gene summary for DNPH1 |
![]() |
Gene information | Species | Human | Gene symbol | DNPH1 | Gene ID | 10591 |
Gene name | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | |
Gene Alias | C6orf108 | |
Cytomap | 6p21.1 | |
Gene Type | protein-coding | GO ID | GO:0000255 | UniProtAcc | O43598 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10591 | DNPH1 | GSM4909281 | Human | Breast | IDC | 4.32e-33 | 7.41e-01 | 0.21 |
10591 | DNPH1 | GSM4909282 | Human | Breast | IDC | 1.38e-05 | 3.35e-01 | -0.0288 |
10591 | DNPH1 | GSM4909285 | Human | Breast | IDC | 2.02e-05 | 2.48e-01 | 0.21 |
10591 | DNPH1 | GSM4909286 | Human | Breast | IDC | 1.56e-10 | 2.04e-01 | 0.1081 |
10591 | DNPH1 | GSM4909290 | Human | Breast | IDC | 3.36e-02 | 3.16e-01 | 0.2096 |
10591 | DNPH1 | GSM4909291 | Human | Breast | IDC | 2.44e-03 | 3.54e-01 | 0.1753 |
10591 | DNPH1 | GSM4909293 | Human | Breast | IDC | 4.82e-02 | 3.73e-02 | 0.1581 |
10591 | DNPH1 | GSM4909294 | Human | Breast | IDC | 2.04e-02 | -1.26e-01 | 0.2022 |
10591 | DNPH1 | GSM4909297 | Human | Breast | IDC | 8.53e-04 | -9.34e-02 | 0.1517 |
10591 | DNPH1 | GSM4909307 | Human | Breast | IDC | 3.68e-20 | 5.75e-01 | 0.1569 |
10591 | DNPH1 | GSM4909308 | Human | Breast | IDC | 3.01e-32 | 7.05e-01 | 0.158 |
10591 | DNPH1 | GSM4909311 | Human | Breast | IDC | 1.70e-18 | -1.21e-03 | 0.1534 |
10591 | DNPH1 | GSM4909312 | Human | Breast | IDC | 4.94e-05 | 1.19e-01 | 0.1552 |
10591 | DNPH1 | GSM4909319 | Human | Breast | IDC | 6.16e-25 | -9.50e-02 | 0.1563 |
10591 | DNPH1 | GSM4909320 | Human | Breast | IDC | 3.22e-03 | 5.56e-03 | 0.1575 |
10591 | DNPH1 | GSM4909321 | Human | Breast | IDC | 2.94e-09 | 1.32e-01 | 0.1559 |
10591 | DNPH1 | brca10 | Human | Breast | Precancer | 7.54e-09 | -3.20e-01 | -0.0029 |
10591 | DNPH1 | NCCBC11 | Human | Breast | DCIS | 4.46e-03 | 1.36e-01 | 0.1232 |
10591 | DNPH1 | NCCBC14 | Human | Breast | DCIS | 1.49e-04 | -4.77e-02 | 0.2021 |
10591 | DNPH1 | NCCBC5 | Human | Breast | DCIS | 1.01e-09 | 1.01e-01 | 0.2046 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004427025 | Thyroid | ATC | cellular nitrogen compound catabolic process | 229/6293 | 451/18723 | 2.25e-14 | 1.27e-12 | 229 |
GO:001604927 | Thyroid | ATC | cell growth | 241/6293 | 482/18723 | 4.27e-14 | 2.35e-12 | 241 |
GO:001943924 | Thyroid | ATC | aromatic compound catabolic process | 232/6293 | 467/18723 | 3.05e-13 | 1.44e-11 | 232 |
GO:190136124 | Thyroid | ATC | organic cyclic compound catabolic process | 238/6293 | 495/18723 | 1.12e-11 | 4.12e-10 | 238 |
GO:000155826 | Thyroid | ATC | regulation of cell growth | 201/6293 | 414/18723 | 1.57e-10 | 4.76e-09 | 201 |
GO:007252128 | Thyroid | ATC | purine-containing compound metabolic process | 189/6293 | 416/18723 | 2.83e-07 | 4.29e-06 | 189 |
GO:0006753111 | Thyroid | ATC | nucleoside phosphate metabolic process | 219/6293 | 497/18723 | 5.92e-07 | 8.29e-06 | 219 |
GO:0009117112 | Thyroid | ATC | nucleotide metabolic process | 215/6293 | 489/18723 | 9.09e-07 | 1.20e-05 | 215 |
GO:000616328 | Thyroid | ATC | purine nucleotide metabolic process | 177/6293 | 396/18723 | 2.39e-06 | 2.82e-05 | 177 |
GO:000912615 | Thyroid | ATC | purine nucleoside monophosphate metabolic process | 25/6293 | 44/18723 | 1.30e-03 | 6.82e-03 | 25 |
GO:003030719 | Thyroid | ATC | positive regulation of cell growth | 74/6293 | 166/18723 | 2.06e-03 | 9.73e-03 | 74 |
GO:000912313 | Thyroid | ATC | nucleoside monophosphate metabolic process | 37/6293 | 76/18723 | 4.57e-03 | 1.89e-02 | 37 |
GO:004592720 | Thyroid | ATC | positive regulation of growth | 106/6293 | 259/18723 | 7.90e-03 | 3.06e-02 | 106 |
GO:19011363 | Thyroid | ATC | carbohydrate derivative catabolic process | 73/6293 | 172/18723 | 9.43e-03 | 3.47e-02 | 73 |
GO:00725232 | Thyroid | ATC | purine-containing compound catabolic process | 26/6293 | 52/18723 | 1.05e-02 | 3.82e-02 | 26 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DNPH1 | insertion | Frame_Shift_Ins | rs754125969 | c.255_256insAAAGC | p.Gln86LysfsTer11 | p.Q86Kfs*11 | O43598 | protein_coding | TCGA-A8-A091-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | PD | ||
DNPH1 | SNV | Missense_Mutation | rs763494634 | c.341N>A | p.Arg114Gln | p.R114Q | O43598 | protein_coding | tolerated(0.31) | benign(0.02) | TCGA-C5-A1ML-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
DNPH1 | SNV | Missense_Mutation | novel | c.274G>A | p.Ala92Thr | p.A92T | O43598 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
DNPH1 | SNV | Missense_Mutation | c.221G>T | p.Arg74Met | p.R74M | O43598 | protein_coding | deleterious(0.01) | possibly_damaging(0.564) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
DNPH1 | SNV | Missense_Mutation | rs749012747 | c.416N>A | p.Arg139Gln | p.R139Q | O43598 | protein_coding | tolerated(0.37) | benign(0) | TCGA-B5-A0K6-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DNPH1 | SNV | Missense_Mutation | c.463G>T | p.Asp155Tyr | p.D155Y | O43598 | protein_coding | deleterious(0) | benign(0.243) | TCGA-G3-A25U-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
DNPH1 | SNV | Missense_Mutation | c.206N>T | p.Ala69Val | p.A69V | O43598 | protein_coding | tolerated(0.1) | benign(0.045) | TCGA-BR-8363-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
DNPH1 | insertion | Frame_Shift_Ins | novel | c.209_210insAT | p.Gly71LeufsTer25 | p.G71Lfs*25 | O43598 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |